Neck Pain Treatment Solutions Market Segmentation:
- By Product
- Cervical Collars
- Traction Devices
- Epidural Steroid Injections
- NSAIDs
- Opioids
- Muscle Relaxants
- Others
- By Application
- Degenerative Disc Disease
- Herniated Discs
- Trauma and Fractures
- Osteoarthritis
- Whiplash Injuries
- Spinal Stenosis
- Others
- By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Physiotherapy Centers
- Home Care Settings
- Others
- By Surgery
- Spinal Fusion
- Disk Replacement
- Foraminotomy
- Diskectomy
- Laminectomy
- Corpectomy
- Others
- By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- North America
-
-
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- Israel
- South Africa
- North Africa
- Central Africa
- Rest of the Middle East
-
Frequently Asked Questions
The Neck Pain Treatment Solutions Market is estimated to be USD 13.2 billion in 2023.
Key growth factors are rising geriatric population, sedentary lifestyles causing posture issues, increase in spinal disorders, advances in minimally invasive procedures and product innovation.
High cost of surgical interventions, unfavorable reimbursement policies, side effects of drugs like opioids and NSAIDs, low awareness in developing regions.
Opioids for pain management dominate the Neck Pain Treatment Solutions Market with over 25% share presently.
Medtronic, Johnson & Johnson, Stryker, Zimmer Biomet, NuVasive, Globus Medical, Orthofix Medical, Integra LifeSciences, DePuy Synthes.
The global Neck Pain Treatment Solutions Market is projected to reach USD 20.3 billion by 2030, growing at a CAGR of 5.5% during 2023-2031.
Rising geriatric population, increase in spinal degenerative disorders, sedentary lifestyles, product innovation, favorable reimbursement policies, and technological advancements.